Organon Biosimilars is here for you every step of the way
Deciding, implementing, and monitoring the adoption of a biosimilar can seem daunting, but Organon Biosimilars is here to help you identify the various steps involved.
For institutions
Roadmap for health care professionals for considering, implementing, and monitoring biosimilar adoption in an institution.
DownloadFor physicians
Roadmap for health care professionals for considering, implementing, and monitoring biosimilar adoption in a private practice setting.
DownloadSpearheading implementation
Before adding any medicine onto formulary, nearly every organization relies on its pharmacy and therapeutics (P&T) committee to conduct a broad and detailed evaluation of the product, including biosimilars.
Key elements of biosimilar formulary review:
Clinical Parameters3
- Indication, MOA, and dosing and administration
- Clinical efficacy and safety
- Immunogenicity
Product
Characteristics3
- Nomenclature
- Supply chain
- Packaging/Labeling
Considerations3
- Cost/Reimbursement
- Pharmacovigilance
- Patient/Provider education
- Tracking and information system implications
What should health system pharmacists know about biosimilars?
Advocating for Biosimilars
Interactive educational resource for pharmacists exploring the potential value biosimilars may bring to the health care system.
Trusting Biosimilars
Interactive educational resource for pharmacists overviewing clinical considerations for biosimilars.